Bugs as drugs: Chr. Hansen and Lonza enter live biotherapeutic products joint venture

Supplier Profiles On NutritionInsight.com
Lonza

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

19 Sep 2019 --- Lonza’s personal care division is launching a new topical ingredient that promotes the appearance of youthful skin and an even skin tone by protecting against... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

30 Aug 2019 --- Chr. Hansen is giving its Danish campus a modern and “future-proof” makeover in response to the increasing demand for natural and sustainable products.... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

29 Aug 2019 --- BacThera is the newly dubbed 50/50 joint venture (JV) from global bioscience company Chr. Hansen and pharma contract manufacturing company Lonza. The new... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

28 Aug 2019 --- Over two million antibiotic courses could be avoided each year if the US population took probiotics, according to a Chr. Hansen-sponsored study published in... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

16 Aug 2019 --- In nutrition news this week, Lonza will be revealing the industry’s first clean label colored capsules for dietary supplement manufacturers at Food... Read More

trans